Prospective observational study to develop the evaluation methods of the gastric cancer pathophysiology and the prediction methods of the anti-cancer therapy response.

Prospective observational study to develop the evaluation methods of the gastric cancer pathophysiology and the prediction methods of the anti-cancer therapy response. - Clinical study to develop the prediction methods of the anti-cancer therapy response.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037487

Enrollment

1000

Registered

2019-07-29

Start date

1977-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary gastric cancer patients who gave informed consent and received the examination of HLA, APRs, cellular immunity, QOL questionnaire, and so on. Patients refused to enroll in RCT or refuse to receive anti-cancer drugs, but want to receive some anti-cancer drugs selected by him/herself, or to HLA oriented therapy. Drugs used were PSK, F, MMC and CDDP.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Overall survival and QOL based on predictors.	—

Secondary

Measure	Time frame
HLA APRs Cellar immunity QOL	—

Countries

Japan

Contacts

Public ContactKyoji Ogoshi

Tokai University Department of Surgery

ogoshi@is.icc.u-tokai.ac.jp0463-96-6163

Outcome results